Oidov Baatarkhuu

Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

Devin Razavi‐Shearer, Ivane Gamkrelidze, Calvin Q. Pan et al. · ˜The œLancet. Gastroenterology & hepatology · 2023 · 404 citations · Full text

Public Health, Infectious Disease Control, Preventive Medicine +13

Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)

Shiv Kumar Sarin, Ashok Choudhury, George Lau et al. · Hepatology International · 2020 · 295 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +12

APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

George Lau, Ming‐Lung Yu, Grace Lai–Hung Wong et al. · Hepatology International · 2021 · 171 citations · Full text

Pharmacy, Immunology, Infectious Diseases +14

A global research priority agenda to advance public health responses to fatty liver disease

Henry E. Mark, Alina M. Allen, Juan Pablo Arab et al. · Journal of Hepatology · 2023 · 132 citations · Full text

Public Affairs, Health Policy, Epidemiology +12

The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic dysfunction-associated fatty liver disease

Mohammed Eslam, Jian‐Gao Fan, Ming‐Lung Yu et al. · Hepatology International · 2025 · 127 citations · Full text

Medicine, Internal Medicine, Hepatology +14